Patel Kinnari

Patel Kinnari is listed in filings as See Remarks at Rocket Pharmaceuticals, Inc.. This profile follows SEC Form 4 activity through May 22, 2025, including sale activity and purchase activity. Recent filings connect the profile to Rocket Pharmaceuticals, Inc. (RCKT). The current snapshot covers public activity from Aug 20, 2024 to May 22, 2025. Reported amounts are shown as $4.9K to $64.3K. The page organizes purchases, sales, issuer links, reported share activity, and filing evidence for review as public disclosure data.